In accordance with this study, Bertrand et al. reported a potentiation of anti-PD-1 treatment efficacy by TNF-antibodies and that TNF signaling impairs the accumulation of tumor infiltrating T cells in mouse melanoma [136]. This evidence concerns the gene PDCD1 and melanoma.